First half 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.


No votes yet
 
Relacionados
ROVI reports operating revenue growth of 12% and net profit growth of 53%
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), compañía farmacéutica paneuropea especializada y dedicada a la investigación,...
6 min
24/11/2020